Highlights
ASX: TDL       TBG DIAGNOSTICS LIMITED
Last Price Today's Change   Day's Range   Trading Volume
0.03   0.00 (0.00%)  0.03 - 0.03  0

Overview

 
Avg Volume (4 weeks):15,311
4 Weeks Range:0.03 - 0.035
4 Weeks Price Volatility (%):
0.00%
52 Weeks Range:0.03 - 0.06
52 Weeks Price Volatility (%):
0.00%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

TBG Diagnostics Limited, formerly Progen Pharmaceuticals Limited, is a biotechnology company. The Company's principal activities include the discovery, research and development of pharmaceutical therapeutics for the treatment of human diseases, and the provision of contract services related to the process development, manufacture and quality assurance of biopharmaceutical products. The Company's segments include Research & Development, and Manufacturing. The Company is primarily engaged in the discovery and development of small molecule-based cancer therapeutics. The Company is focused on the development of the anti-angiogenesis and anti-metastatic oncology products pipeline. The Company's offerings include Muparfostat (PI-88) and PG545. Muparfostat (PI-88) is an anti-angiogenesis and anti-metastatic compound. Muparfostat (PI-88) is a dual angiogenesis and heparanase inhibitor. PG545 is an agent designed to target the tumor microenvironment.

  Be the first to like this.
 


 

555  649  673  9296 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 ANL 0.0030.00 
 CTM 0.011+0.002 
 AMP 1.735-0.09 
 MSE 0.019+0.008 
 TLS 3.77-0.10 
 BLK 0.0140.00 
 SWM 0.40+0.025 
 MEI 0.039+0.003 
 CWY 2.11+0.06 
 LNY 0.0090.00 
Partners & Brokers